Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens
-
Published:2024-09
Issue:1
Volume:120
Page:33-35
-
ISSN:0360-3016
-
Container-title:International Journal of Radiation Oncology*Biology*Physics
-
language:en
-
Short-container-title:International Journal of Radiation Oncology*Biology*Physics
Author:
Desai Neil B.ORCID,
Nagar Himanshu
Reference10 articles.
1. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial;Tree;Lancet Oncol,2022
2. PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis;As;J Clin Oncol,2023
3. Effect of standard versus dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG oncology RTOG 0126 randomized clinical trial;Michalski;JAMA Oncol,2018
4. Randomized trial of hypofractionated, dose-escalated, intensity-modulated radiation therapy (IMRT) versus conventionally fractionated IMRT for localized prostate cancer;Hoffman;J Clin Oncol,2018
5. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: Results of a prospective multicenter study of 166 patients;Goldner;Int J Radiat Oncol Biol Phys,2007